In addition, we previously demonstrated5 that adiponectin levels are modulated by the Ig treatment specifically in CVID patients already at 24 h considering this cytokine as a biomarker for the replacement therapy in CVID patients. Here, ADIPOQ is linked to common variable immunodeficiency.